July 9, 2025 — The American Society for Radiation Oncology (ASTRO) selected 43 members to receive the ASTRO Fellow (FASTRO) designation this year. This prestigious honor recognizes ASTRO members’ outstanding achievements and contributions to the Society, cancer research, education, patient care and the specialty. The new Fellows will be recognized at ASTRO’s 67th Annual Meeting in San Francisco in September.

July 8, 2025 — QT Imaging Holdings, has appointed Elaine Iuanow, MD, as chief medical officer (CMO) and Kim Du as senior director of clinical operations. These additions to the leadership team significantly enhance the company’s medical and clinical capabilities as QTI expands its clinical studies as well as the development of AI-driven lesion classification and second-read decision support tools alongside the commercialization of its FDA-cleared QTI Breast Acoustic CT™ scanner.

July 2, 2025 — Lunit, a provider of AI for cancer diagnostics and therapeutics, has announced a collaboration with Microsoft to accelerate the delivery of AI-powered healthcare solutions. In conjunction with their recent acquisition of Volpara, a Microsoft Industry Health Certified Partner, this collaboration will give health professionals globally access to tools that will assist in the detection of cancer.

July 7, 2025 — SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, has launched Mammogram+ and Mammogram+ Heart, two new AI-enhanced mammogram services aimed at improving early detection and advancing preventative care.

July 8, 2025 — Mendaera, Inc., a healthcare technology company focused on developing robotics that can be deployed universally in medicine, recently announced  it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its handheld robotic system, Focalist. The novel system is designed to simplify and enhance the precision of ultrasound-guided needle placement — a technically demanding procedure performed across many specialties and care settings. The company is commencing a limited launch with select medical institutions.

July 01, 2025 — NANO-X Imaging Ltd. recently announced a clinical and educational collaboration with Keiser University, one of Florida’s largest private, non-profit university.

July 2, 2025 — Philips has received FDA 510(k) clearance for SmartSpeed Precise1 MR’s latest deep learning reconstruction software, marking a major milestone in the journey toward autonomous, personalized MRI. SmartSpeed Precise is the industry's first integrated dual AI solution, delivering up to 3x faster scanning2 and up to 80% sharper images3 —  in one click. 

Multimodal AI Shows No Evidence of Bias in Prostate Cancer Study

A new study published in JCO Clinical Cancer Informatics tackles a critical challenge in cancer diagnostics: ensuring that artificial intelligence (AI) performs equitably across racially diverse patient populations. This research marks a milestone in prostate cancer care, presenting the first large-scale comparative analysis of a digital pathology AI prognostic model in both African American and non–African American patients. The findings offer key insights into the performance of AI in addressing bias in oncologic outcomes.

July 1, 2025 — UPDATE: The final paper is now available at:

JMIR AI - ChatGPT-4–Driven Liver Ultrasound Radiomics Analysis: Diagnostic Value and Drawbacks in a Comparative Study

 

ORIGINALLY POSTED June 3, 2025 — In a collaborative study between the Departments of Radiology at the Children’s Hospital of Philadelphia (CHOP) and the University of Pennsylvania, researchers evaluated the potential of using ChatGPT-4 for diagnosing liver disease using ultrasound images.

June 26, 2025 — Fujifilm VisualSonics Inc., a provider of ultra-high frequency ultrasound and photoacoustic imaging systems, has announced the availability of the multi-modal Vevo F2 LAZR-X20 Photoacoustic Imaging Platform. The system features high-powered, intelligent laser technology for advanced tissue characterization with high anatomical accuracy for preclinical animal models.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now